Literature DB >> 6871676

Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.

W Lang, H Henke.   

Abstract

Muscarinic and nicotinic cholinergic receptor distribution was studied by dry-mount autoradiography in brains obtained postmortem from patients with senile dementia of Alzheimer-type (SDAT) and non-neurological controls. Sections were incubated with either [N-methyl-3H]scopolamine, ([3H]NMS) or [125I]alpha-bungarotoxin, ([125I]alpha-BTX). No significant difference in the affinity and number of muscarinic and nicotinic receptors was found in hippocampus, frontal, temporal and cingulate cortex between SDAT patients and non-neurological controls. However, some SDAT cases showed diffuse instead of laminar [3H]NMS labeling in cortical regions. The labeling pattern was not affected by the presence of neuritic plaques and neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871676     DOI: 10.1016/0006-8993(83)90879-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia.

Authors:  E D London; M J Ball; S B Waller
Journal:  Neurochem Res       Date:  1989-08       Impact factor: 3.996

3.  The laminar distribution of neuritic plaques in the fascia dentata of patients with Alzheimer's disease.

Authors:  B J Crain; P C Burger
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

Authors:  Yongjun Gao; Ronnie C Mease; Thao T Olson; Kenneth J Kellar; Robert F Dannals; Martin G Pomper; Andrew G Horti
Journal:  Nucl Med Biol       Date:  2014-12-20       Impact factor: 2.408

5.  Localization of monoamine oxidase B in human brain by autoradiographical use of 11C-labelled L-deprenyl.

Authors:  S S Jossan; R d'Argy; P G Gillberg; S M Aquilonius; B Långström; C Halldin; P Bjurling; C G Stålnacke; J Fowler; R MacGregor
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

7.  Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.

Authors:  E K Perry; R H Perry; C J Smith; D J Dick; J M Candy; J A Edwardson; A Fairbairn; G Blessed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

8.  Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

Authors:  D J Wyper; D Brown; J Patterson; J Owens; R Hunter; E Teasdale; J McCulloch
Journal:  Eur J Nucl Med       Date:  1993-05

Review 9.  Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist.

Authors:  W R Kem
Journal:  Invert Neurosci       Date:  1997 Sep-Dec

Review 10.  Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.

Authors:  Changiz Geula; Sara R Dunlop; Ivan Ayala; Allegra S Kawles; Margaret E Flanagan; Tamar Gefen; Marek-Marsel Mesulam
Journal:  J Neurochem       Date:  2021-08-06       Impact factor: 5.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.